Pharming Group (PHAR)
NASDAQ:PHAR

Pharming Group (PHAR) Technical Analysis

93 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Pharming Group is a Sell.
Pharming Group’s (PHAR) 20-Day exponential moving average is 8.47, while Pharming Group’s (PHAR) share price is $8.51, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 8.79, while Pharming Group’s (PHAR) share price is $8.51, making it a Sell.

Pharming Group (PHAR) Pivot Points

Jul 26, 2024, 01:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.59
8.64
8.70
8.75
8.82
8.87
8.93
Fibonacci
8.64
8.68
8.71
8.75
8.80
8.83
8.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Jul 26, 2024, 01:39 PM
Period
Simple
Exponential
MA5
8.67Sell
8.62Sell
MA10
8.52Sell
8.54Sell
MA20
8.27Buy
8.47Buy
MA50
8.69Sell
8.79Sell
MA100
9.70Sell
9.50Sell
MA200
10.70Sell
10.47Sell
Pharming Group’s (PHAR) 10-Day exponential moving average is 8.54, while Pharming Group’s (PHAR) share price is $8.51, making it a Sell.
Pharming Group’s (PHAR) 100-Day exponential moving average is 9.50, while Pharming Group’s (PHAR) share price is $8.51, making it a Sell.
Pharming Group’s (PHAR) stock price is $8.51 and Pharming Group’s (PHAR) 50-day simple moving average is 8.69, creating a Sell signal.
Pharming Group’s (PHAR) stock price is $8.51 and Pharming Group’s (PHAR) 100-day simple moving average is 9.70, creating a Sell signal.
Pharming Group’s (PHAR) stock price is $8.51 and Pharming Group’s (PHAR) 200-day simple moving average is 10.70, creating a Sell signal.

Pharming Group (PHAR) Technical Indicators

Jul 26, 2024, 01:39 PM
Name
Value
Implied Action
RSI (14)
50.13
Neutral
STOCH (9,6)
76.72
Neutral
STOCHRSI (14)
77.12
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
15.06
Buy
Williams %R
-39.28
Buy
CCI (14)
56.24
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
51.50
Neutral
ROC
1.92
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 50.13, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 15.06, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 56.24, creating a Neutral signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 1.92, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Sell.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 50.13, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.02, which suggests PHAR is a Sell.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 8.67, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 8.27, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 8.69, which suggests PHAR is a Sell.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 10.70, which suggests PHAR is a Sell.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -39.28, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 56.24, which suggests PHAR is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis